中国のPOCT(ポイント・オブ・ケア・テスト)機器市場(2014-2018)

◆英語タイトル:POCT Market in China 2014-2018
◆商品コード:IRTNTR4131
◆発行会社(調査会社):Technavio
◆発行日:2014年9月10日
◆ページ数:76
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥319,200見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥399,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。



【レポートの概要】

About POCT
POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients’ quality of life.

TechNavio’s analysts forecast the POCT market in China to grow at a CAGR of 20.69 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the POCT market in China for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the following applications of POCT:
• Blood glucose testing
• Cholesterol testing
• Infectious disease testing
• Blood gas testing
• Cardiac biomarkers testing
• Pregnancy testing
• Others (such as cancer biomarker, electrolyte analyzers, blood coagulation testing, tumor marker, and urinalysis testing)

TechNavio’s report, the POCT Market in China 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers China; it also covers the landscape of the POCT market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Region
• China

Key Vendors
• Abbott Laboratories
• Bayer HealthCare
• F. Hoffmann-La Roche
• LifeScan

Other Prominent Vendors
• Bioptik Technology
• Chongqing Haray International Business
• Fudakang Ind’l
• Guangzhou Maya Medical Equipment
• Jiangxi Zhongchenda Industrial Investment
• Nantong Voyage International Trade
• Shenzhen Fitconn Technology
• Shiny Health Import & Export
• Sunrising Enterprise
• Wuhan HNC Technology
• Yuan Yu Bio-Tech

Market Driver
• Technological Innovations
• For a full, detailed list, view our report

Market Challenge
• Advances in Technology
• For a full, detailed list, view our report

Market Trend
• Expanding Economy of China
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【レポートの目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1 Blood Glucose Testing Market in China
07.1.1 Market Size and Forecast
07.2 Cholesterol Testing Market in China
07.2.1 Market Size and Forecast
07.3 Infectious Disease Testing Market in China
07.3.1 Market Size and Forecast
07.4 Blood Gas Testing Market in China
07.4.1 Market Size and Forecast
07.5 Cardiac Biomarkers Testing Market in China
07.5.1 Market Size and Forecast
07.6 Pregnancy Testing Market in China
07.6.1 Market Size and Forecast
08. Market Segmentation by Technology
08.1 Electrochemical Biosensors
08.2 Optical Biosensors
08.3 Piezoelectric Biosensors
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.2 Market Share Analysis 2013
16.3 Other Prominent Vendors
16.4 Abbott Laboratories
16.4.1 Key Facts
16.4.2 Business Overview
16.4.3 Business Segmentation by Revenue 2012
16.4.4 Business Segmentation by Revenue 2011 and 2012
16.4.5 Geographical Segmentation by Revenue 2012
16.4.6 Business Strategy
16.4.7 Key Information
16.4.8 SWOT Analysis
16.4.9 Strengths
16.4.10 Weakness
16.4.11 Opportunities
16.4.12 Threats
16.5 Bayer HealthCare
16.5.1 Key Facts
16.5.2 Business Overview
16.5.3 Business Segmentation by Revenue 2013
16.5.4 Business Segmentation by Revenue 2012 and 2013
16.5.5 Geographical Segmentation by Revenue 2013
16.5.6 Business Strategy
16.5.7 Recent Developments
16.5.8 SWOT Analysis
16.5.9 Strengths
16.5.10 Weaknesses
16.5.11 Opportunities
16.5.12 Threats
16.6 LifeScan
16.6.1 Key Facts
16.6.2 Business Overview
16.6.3 Product Segmentation
16.6.4 Geographical Segmentation by Revenue 2013
16.6.5 Business Strategy
16.6.6 Recent Developments
16.6.7 SWOT Analysis
16.6.8 Strengths
16.6.9 Weaknesses
16.6.10 Opportunities
16.6.11 Threats
16.7 F. Hoffmann La Roche
16.7.1 Key Facts
16.7.2 Business Overview
16.7.3 Business Segmentation by Revenue 2013
16.7.4 Business Segmentation by Revenue 2012 and 2013
16.7.5 Sales by Geography 2013
16.7.6 Business Strategy
16.7.7 Recent Developments
16.7.8 SWOT Analysis
16.7.9 Strengths
16.7.10 Weaknesses
16.7.11 Opportunities
16.7.12 Threats

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: POCT market in China 2013-2018 (US$ million)
Exhibit 3: POCT Market in China Segmentation by Application
Exhibit 4: POCT Market in China Segmentation by Application 2013
Exhibit 5: Blood Glucose Testing Market in China 2013-2018 (US$ million)
Exhibit 6: Cholesterol Testing Market in China 2013-2018 (US$ million)
Exhibit 7: Infectious Disease Testing Market in China 2013-2018 (US$ million)
Exhibit 8: Blood Gas Testing Market in China 2013-2018 (US$ million)
Exhibit 9: Cardiac Biomarkers Testing Market in China 2013-2018 (US$ million)
Exhibit 10: Pregnancy Testing Market in China 2013-2018 (US$ million)
Exhibit 11: POCT market in China Segmentation by Application 2013-2018
Exhibit 12: POCT Market Segmentation by Technology in China
Exhibit 13: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 14: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 15: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 16: Bayer Healthcare: Business Segmentation by Revenue 2013
Exhibit 17: Bayer Healthcare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 18: Bayer Healthcare: Geographical Segmentation by Revenue 2013
Exhibit 19: LifeScan: Product Segmentation 2013
Exhibit 20: LifeScan: Geographical Segmentation by Revenue 2013
Exhibit 21: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 22: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 23: F. Hoffmann-La Roche: Sales of Pharmaceuticals Division by Geography 2013
Exhibit 24: F. Hoffmann-La Roche: Sales of Diagnostics Division by Geography 2013



【掲載企業】

Abbott Laboratories ,Bayer HealthCare,F. Hoffmann-La Roche,LifeScan,Bioptik Technology,Chongqing Haray International Business,Fudakang Ind'l,Guangzhou Maya Medical Equipment,Jiangxi Zhongchenda Industrial Investment,Nantong VoyageInternational Trade,Shenzhen Fitconn Technology,Shiny Health Import & Export,Sunrising Enterprise,Wuhan HNC Technology,Yuan Yu Bio-Tech

【レポートのキーワード】

POCT(ポイント・オブ・ケア・テスト)、POC検査、医療機器、血糖テスト、コレステロールテスト、感染症検査、血液ガス・テスト

【調査方法】

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[中国のPOCT(ポイント・オブ・ケア・テスト)機器市場(2014-2018)]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月08日現在 219,203 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆